Cormorant Asset Management’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $1.42M | Hold |
|
|||||
2022
Q4 | $1.62M | Buy |
|
|||||
2022
Q3 | $1.42M | Buy |
|
|||||
2022
Q2 | $100K | Hold |
|
|||||
2022
Q1 | $182K | Hold |
|
|||||
2021
Q4 | $238K | Hold |
|
|||||
2021
Q3 | $550K | Hold |
|
|||||
2021
Q2 | $676K | Hold |
|
|||||
2021
Q1 | $895K | Hold |
|
|||||
2020
Q4 | $669K | Buy |
|
|||||
2020
Q3 | – | Sell |
|
|||||
2020
Q2 | $1.76M | Sell |
|
|||||
2020
Q1 | $3.42M | Buy |
|
|||||
2019
Q4 | $2.7M | Sell |
|
|||||
2019
Q3 | $11.2M | Sell |
|
|||||
2019
Q2 | $13.4M | Buy |
|
|||||
2019
Q1 | $4.4M | Sell |
|
|||||
2018
Q4 | $4.32M | Buy |
|